GLTA : looks like hv to wait longer... US Time (1795) (Supplementary Announcement) and Alvogen US Suspend Joint Acquisition of NeuroRx Inc.'s Exclusive Development, Manufacture and Worldwide Sales Rights for Manic Depression NRX-101 (6/21 yen share price $290) - Biotechnology Investment First - Genet Point of View
GLTA : looks like hv to wait longer... US Time (1795) (Supplementary Announcement) and Alvogen US Suspend Joint Acquisition of NeuroRx Inc.'s Exclusive Development, Manufacture and Worldwide Sales Rights for Manic Depression NRX-101 (6/21 yen share price $290) - Biotechnology Investment First - Genet Point of View